Newly Issued Technology Coverage Statement on Minimally Invasive Surgical Options for GERD REDMOND, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that Health Care...
REDMOND, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the American Gastroenterological Association (AGA) has issued a Technology Coverage Statement on Minimally...
Latest EsophyX® Z Fastener Delivery System Significantly Reduces the Number of Steps in the TIF® (Transoral Incisionless Fundoplication) Procedure REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal...
REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the results of a meta-analysis demonstrating that EGS’ Transoral Incisionless Fundoplication (TIF®) procedure...
